학술논문

Under-Representation of Diverse Populations and Glycemic Outcomes in Major Clinical Trials of Automated Insulin Delivery.
Document Type
Article
Source
Diabetes Technology & Therapeutics. Oct2023, Vol. 25 Issue 10, p752-754. 3p.
Subject
*CLINICAL trials
*TYPE 1 diabetes
*INSULIN
*CULTURAL pluralism
*AMERICAN Community Survey
Language
ISSN
1520-9156
Abstract
Racial disparities in diabetes technology use and outcomes in type 1 diabetes in a safety-net hospital. Failure to find differences between race/ethnicity groups in baseline and post-AID glycemic metrics may have been due to the small sample size and higher income/education levels of our MRE participants. Dear Editor, Individuals with type 1 diabetes of minoritized racial/ethnic (MRE) groups and low-socioeconomic status (SES) access and use advanced diabetes technology at lower rates compared with non-Hispanic White (NHW) and high SES populations,[1] which has been associated with worse glycemic outcomes.[2] In addition to lower technology use, individuals of MRE groups, especially non-Hispanic Black and Hispanic groups, are vastly under-represented in diabetes technology clinical trials. [Extracted from the article]